PDR; PVR; Ozurdex
Showing 1 - 25 of 332
Diabetic Retinopathy Trial (slow-release dexamethasone implant)
Not yet recruiting
- Diabetic Retinopathy
- slow-release dexamethasone implant
- (no location specified)
Jun 8, 2022
Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- +3 more
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 6, 2023
Diabetic Retinopathy, Retinal Detachment Trial in Montemorelos (PPV/SO, PPV/C3F8)
Completed
- Diabetic Retinopathy
- Retinal Detachment
- PPV/SO
- PPV/C3F8
-
Montemorelos, Nuevo Leon, MexicoHospital La Carlota
Nov 20, 2021
Diabetic Macular Edema Trial in France (Dexamethasone with 2 loading doses followed by PRN regimen.)
Recruiting
- Diabetic Macular Edema
- Dexamethasone with 2 loading doses followed by PRN regimen.
-
Avignon, France
- +19 more
Feb 25, 2022
Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance
Completed
- Diabetic Macular Edema
- +2 more
- dexamethasone intravitreal implant
- intravitreal bevacizumab
-
Torrance, CaliforniaRetina Macula Institute
Mar 8, 2021
OCT and OCT-A Afer Diabetic Vitrectomy in PDR
Not yet recruiting
- Proliferative Diabetic Retinopathy
- OCT and OCT-A
- (no location specified)
Jul 4, 2023
Uveitis, Posterior, Uveitis, Intermediate, Panuveitis Trial (Ozurdex 0.7mg Ophthalmic Implant, Prednisone)
Recruiting
- Uveitis, Posterior
- +2 more
- Ozurdex 0.7mg Ophthalmic Implant
- Prednisone
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute - Vision Research Centre
Dec 14, 2022
Proliferative Diabetic Retinopathy Trial in Beijing (IVA injection before vitrectomy)
Completed
- Proliferative Diabetic Retinopathy
- IVA injection before vitrectomy
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Jul 26, 2022
Pulmonary Hypertension (World Health Organization Group 2), Heart Failure Trial (AZD3427, Placebo)
Not yet recruiting
- Pulmonary Hypertension (World Health Organization Group 2)
- Heart Failure
- AZD3427
- Placebo
- (no location specified)
Feb 17, 2023
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)
Completed
- Proliferative Diabetic Retinopathy
- preoperative intravitreal injections of ranibizumab or conbercept
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 7, 2022
Diabetic Macular Edema Trial in Portugal, Spain (Dexamethasone Intravitreal Implant)
Completed
- Diabetic Macular Edema
- Dexamethasone Intravitreal Implant
-
Coimbra, Portugal
- +25 more
Oct 5, 2022
Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab
Recruiting
- Diabetic Retinopathy
- +3 more
- Ranibizumab Injection
- PPV
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 11, 2022
Voiding Disorders, Voiding Dysfunction Trial in New Haven (Butterfly portable ultrasound device with bladder ultrasound images,
Completed
- Voiding Disorders
- Voiding Dysfunction
- Butterfly portable ultrasound device with bladder ultrasound images
- Butterfly portable ultrasound device with abstract bladder images
-
New Haven, ConnecticutYale New Haven Hospital
Jan 12, 2023
Proliferative Diabetic Retinopathy Trial in Beijing (proactive Anti-VEGF (conbercept) use, passive Anti-VEGF (conbercept) use)
Recruiting
- Proliferative Diabetic Retinopathy
- proactive Anti-VEGF (conbercept) use
- passive Anti-VEGF (conbercept) use
-
Beijing, Beijing, ChinaPeking University Third Hospital
Dec 13, 2022
Pro-permeability and Pro-fibrosis Factors in Aqueous of Retinal
Terminated
- Macular Edema
- Fibrosis of the Retina
- Ozurdex
- +2 more
-
Baltimore, MarylandWilmer Eye Institute
Jul 5, 2022
Prophylactic PRP in Moderate NPDR
Completed
- Eye Diseases
- +2 more
- PRP
-
Assiut, EgyptAssiut University
Sep 14, 2022
Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low
Completed
- Rhegmatogenous Retinal Detachment
- High-risk for Proliferative Vitreoretinopathy (PVR)
- 5-fluorouracil and low molecular weight heparin
- Placebo
-
Freiburg, BW, Germany
- +12 more
Apr 4, 2022
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
Retinal Detachment With Multiple Breaks, Unspecified Eye, Proliferative Vitreoretinopathy Trial in Philadelphia (Intravitreal
Recruiting
- Retinal Detachment With Multiple Breaks, Unspecified Eye
- Proliferative Vitreoretinopathy
- Intravitreal aflibercept injection
- Sham control
-
Philadelphia, PennsylvaniaWills Eye Hospital
May 2, 2022
Cigarette Smoking Trial in Champasak, Vientiane (Nicotine patch, Self-help materials (to support smoking cessation,
Recruiting
- Cigarette Smoking
- Nicotine patch
- +2 more
-
Champasak, Lao People's Democratic Republic
- +1 more
Jun 17, 2022
Retinal Detachment, Proliferative Vitreoretinopathy Trial (Control group, Intervention group)
Not yet recruiting
- Retinal Detachment
- Proliferative Vitreoretinopathy
- Control group
- Intervention group
- (no location specified)
Sep 9, 2022
Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)
Completed
- Proliferative Diabetic Retinopathy
- preoperative group and intraoperative group
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Jun 1, 2022
Pain, Monitoring, Intraoperative Trial in Edegem (PDR measurement)
Completed
- Pain
- Monitoring, Intraoperative
- PDR measurement
-
Edegem, Antwerp, BelgiumUniversity hospital Antwerp
May 17, 2022